Stephen Friend: Congress Summary Keynote

Watch Full Program

Sage Bionetworks Commons Congress 2011

Sage Bionetworks





MORE >>

Post to

Likes

Dislikes

RATE

381 Views

Info
Bio
Chapters
Preview
Download
More

Partner:: Sage Bionetworks
Location:: Mission Bay Conference Center
1675 Owens Street San Francisco, CA
Event Date:: 04.16.11
Speaker:: Stephen H. Friend
Tags:

Summary: Stephen Friend: Congress Summary Keynote

APRIL 16, 2011 -- PART 3: COMMITMENTS FOR 2011

The final part of the Congress will connect the strands of day 1 and consider what can be done. There will be a keynote on how communities can effect change followed by reports from the five Communities of Interest, concluding with a session where attendees will be asked what they want to do, or will do, as a follow-up to the Congress. Attendees will film each other outlining their commitments as part of both the larger Commons community and as part of their Community of Interest. There will then be a closing keynote including a report on the large "game changer" by Stephen Friend.

At the conclusion of the Congress attendees will understand how their own work connects to the greater movement of change in how we must approach biology and how biology relates to health care. Participants will be challenged to articulate how their work from the previous day and over the next year might lead to more sharing, better resource allocation, and faster progress. Participants will have established a set of communities ready to do active work.

Bio

Stephen H. Friend

Dr. Friend is the President and Director of Sage Bionetworks. He was previously Senior Vice President and Franchise Head for Oncology Research at Merck & Co., Inc. where he led Merck's Basic Cancer Research efforts. In 2005, he led the Advanced Technologies and Oncology groups to firmly establish molecular profiling activities throughout Merck's laboratories around the world, as well as to coordinate oncology programs from Basic Research through phase IIA clinical trials.

Prior to joining Merck, Dr. Friend was recruited by Dr. Leland Hartwell to join the Fred Hutchinson Cancer Research Center's Seattle Project, an advanced institute for drug discovery. While there Dr. Friend and Dr. Hartwell developed a method for examining large patterns of genes that led them to co-found Rosetta Inpharmatics in 2001. Dr. Friend has also held faculty positions at Harvard Medical School from 1987 to 1995 and at Massachusetts General Hospital from 1990 to 1995. He received his B.A. in philosophy, his Ph.D. in biochemistry and his M.D. from Indiana University.